|
1
|
Murphey MD, Arcara LK and Fanburg-Smith J:
Imaging of musculoskeletal liposarcoma with Radiologic-pathologic
correlation1. Radiographics. 25:1371–1395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molina G, Hull MA, Chen YL, DeLaney TF, De
Amorim Bernstein K, Choy E, Cote G, Harmon DC, Mullen JT and Haynes
AB: Preoperative radiation therapy combined with radical surgical
resection is associated with a lower rate of local recurrence when
treating unifocal, primary retroperitoneal liposarcoma. J Surg
Oncol. 114:814–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi JH and Ro JY: The 2020 WHO
Classification of tumors of soft tissue: Selected changes and new
entities. Adv Anat Pathol. 28:44–58. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bill KL, Casadei L, Prudner BC, Iwenofu H,
Strohecker AM and Pollock RE: Liposarcoma: Molecular targets and
therapeutic implications. Cell Mol Life Sci. 73:3711–3718. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tfayli Y, Baydoun A, Naja AS and Saghieh
S: Management of myxoid liposarcoma of the extremity. Oncol Lett.
22:5962021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pérez-Losada J, Sánchez-Martín M,
Rodríguez-García MA, Pérez-Mancera PA, Pintado B, Flores T,
Battaner E and Sánchez-Garćia I: Liposarcoma initiated by
FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the
pathogenesis of liposarcoma. Oncogene. 19:6015–6022. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Antonescu CR, Tschernyavsky SJ, Decuseara
R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum
JR and Ladanyi M: Prognostic impact of P53 status, TLS-CHOP fusion
transcript structure, and histological grade in myxoid liposarcoma:
A molecular and clinicopathologic study of 82 cases. Clin Cancer
Res. 7:3977–3987. 2001.PubMed/NCBI
|
|
8
|
Wang L, Luo R, Xiong Z, Xu J and Fang D:
Pleomorphic liposarcoma. Medicine. 97:e99862018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wan L, Tu C, Qi L and Li Z: Survivorship
and prognostic factors for pleomorphic liposarcoma: A
population-based study. J Orthop Surg Res. 16:1752021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tyler R, Wanigasooriya K, Taniere P,
Almond M, Ford S, Desai A and Beggs A: A review of retroperitoneal
liposarcoma genomics. Cancer Treat Rev. 86:1020132020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Titulaer MJ and Verschuuren JJ:
Lambert-Eaton myasthenic syndrome: Tumor versus nontumor forms.
Annals of the New York Academy of Sciences. 1132:129–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Keung EZ, Hornick JL, Bertagnolli MM,
Baldini EH and Raut CP: Predictors of outcomes in patients with
primary retroperitoneal dedifferentiated liposarcoma undergoing
surgery. J Am Coll Surg. 218:206–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu B, Liu Y, Cheng L, Li W and Cao X:
SPECT/CT imaging of retroperitoneal extraskeletal osteosarcoma.
Clin Nucl Med. 39:200–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
von Mehren M, Kane JM, Agulnik M, Bui MM,
Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ,
et al: Soft tissue sarcoma, version 2.2022, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 20:815–833. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Callegaro D and Gronchi A: Radiotherapy in
retroperitoneal liposarcoma: Are We Looking for an Answer in the
Wrong Place? Ann Surg Oncol. 306:675–677. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schwartz LH, Litière S, de Vries E, Ford
R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J,
et al: RECIST 1.1-Update and clarification: From the RECIST
committee. Eur J Cancer. 62:132–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taguchi S, Kume H, Fukuhara H, Morikawa T,
Kakutani S, Takeshima Y, Miyazaki H, Suzuki M, Fujimura T, Nakagawa
T, et al: Symptoms at diagnosis as independent prognostic factors
in retroperitoneal liposarcoma. Mol Clin Oncol. 4:255–260. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamper L, Brandt AS, Scharwächter C, Kukuk
S, Roth S, Haage P and Piroth W: MR evaluation of retroperitoneal
fibrosis. RoFo. 183:721–726. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sung MS, Kang HS, Suh JS, Lee JH, Park JM,
Kim JY and Lee HG: Myxoid liposarcoma: Appearance at MR imaging
with histologic correlation. Radiographics. 20:1007–1019. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Munoz P, Bretcha-Boix P, Artigas V and
Asencio JM: Surgical principles of primary retroperitoneal sarcoma
in the era of personalized treatment: A review of the frontline
extended surgery. Cancers (Basel). 14:40912022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mussi C, Colombo P, Bertuzzi A, Coladonato
M, Bagnoli P, Secondino S, Navarria P, Morenghi E, Santoro A and
Quagliuolo V: Retroperitoneal sarcoma: Is it time to change the
surgical policy? Ann Surg Oncol. 18:2136–2142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
MacNeill AJ, Miceli R, Strauss DC,
Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro
D, Hayes AJ, Honoré C, et al: Post-relapse outcomes after primary
extended resection of retroperitoneal sarcoma: A report from the
Trans-Atlantic RPS Working Group. Cancer. 23:1971–1978. 2017.
View Article : Google Scholar
|
|
23
|
Tan MC, Brennan MF, Kuk D, Agaram NP,
Antonescu CR, Qin LX, Moraco N, Crago AM and Singer S:
Histology-based Classification predicts pattern of recurrence and
improves risk stratification in primary retroperitoneal sarcoma.
Annals Surg. 263:593–600. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miao C, Liu D, Zhang F, Wang Y, Zhang Y,
Yu J, Zhang Z, Liu G, Li B, Liu X and Luo C: Association of FPGS
genetic polymorphisms with primary retroperitoneal liposarcoma. Sci
Rep. 5:90792015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Vita A, Mercatali L, Recine F, Pieri F,
Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G,
Amadori D and Ibrahim T: Current classification, treatment options,
and new perspectives in the management of adipocytic sarcomas. Onco
Targets Ther. 9:6233–6246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Vita A, Recine F, Miserocchi G, Pieri
F, Spadazzi C, Cocchi C, Vanni S, Liverani C, Farnedi A, Fabbri F,
et al: The potential role of the extracellular matrix in the
activity of trabectedin in UPS and L-sarcoma: Evidences from a
patient-derived primary culture case series in tridimensional and
zebrafish models. J Exp Clin Cancer Res. 40:1652021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Antman K, Crowley J, Balcerzak SP, Rivkin
SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL,
et al: An intergroup phase III randomized study of doxorubicin and
dacarbazine with or without ifosfamide and mesna in advanced soft
tissue and bone sarcomas. J Clin Oncol. 11:1276–1285. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bramwell VHC, Anderson D and Charette MLL;
Sarcoma Disease Site Group, : Doxorubicin-based chemotherapy for
the palliative treatment of adult patients with locally advanced or
metastatic soft tissue sarcoma. Cochrane Database Syst Rev.
2003:CD0032932003.PubMed/NCBI
|
|
29
|
Horowitz J, Singhal M, Marrero D,
Bashjawish F, Leto D, Winters M and Jeberaeel J: A Multi-Modality
treatment of retroperitoneal De-Differentiated liposarcoma. Am J
Case Rep. 21:e9192452020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tatenuma T, Mizuno N, Jikuya R, Hashizume
A, Yasui M, Umemoto S, Kawai M, Hiruma T and Kishida T:
Retroperitoneal liposarcoma with multiple recurrence of lung
metastases treated by multimodal therapy centering on the
operation: A case report. Nihon Hinyokika Gakkai Zasshi. 109:25–29.
2018.(In Japanese). PubMed/NCBI
|
|
31
|
Mulita F, Verras GI, Liolis E,
Tchabashvili L, Kehagias D, Kaplanis C, Perdikaris I and Kehagias
I: Recurrent retroperitoneal liposarcoma: A case report and
literature review. Clin Case Rep. 9:e047172021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Niemetz I, Faß J and Wolf M: Multiple
recurrent retroperitoneal liposarcoma in a 66-year-old man.
Internist (Berl). 61:217–222. 2020.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nagy V, Bober J, Zavacky P, Brandebur O Jr
and Svajdler M: The recurrent primary retroperitoneal liposarcoma.
Bratisl Lek Listy. 114:662–667. 2013.PubMed/NCBI
|
|
34
|
Kanthala L, Ray S, Aurobindo Prasad Das S,
Nundy S and Mehta N: Recurrent giant retroperitoneal liposarcoma:
Review of literature and a rare case report. Ann Med Surg (Lond).
65:1023292021.PubMed/NCBI
|
|
35
|
Ramu D, Manjunath S and Anuradh G:
Recurrent retroperitoneal liposarcoma: A case report and literature
review. Indian J Surg Oncol. 9:640–643. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
El-Helou E, Alimoradi M, Sabra H, Naccour
J, Haddad MM and Bitar H: Recurrent giant retroperitoneal
liposarcoma with 10 years follow up. Case report and review of
literature. Int J Surg Case Rep. 75:504–512. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nukada S, Aoyama T, Kamiya M, Amano S,
Tamura S, Harada H, Sato T, Yukawa N, Oshima T, Rino Y and Masuda
M: A case of retroperitoneal liposarcoma resected 6 times in 24
years. Gan To Kagaku Ryoho. 45:106–108. 2018.(In Japanese).
PubMed/NCBI
|
|
38
|
Li RSO, Maglangit SACA, Cartagena-Lim JT
and Dofitas RB: Case of a huge recurrent retroperitoneal
liposarcoma diagnosed in the second trimester of pregnancy. BMJ
Case Rep. 14:e2436392021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo S, Xu Y, Qian F, Ma J, Wang S, Chen P
and Zong L: A recurrent giant retroperitoneal myxoid liposarcoma: A
case report and literature review. Transl Cancer Res. 8:2672–2676.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ono Y, Aoyama T, Morita J, Amano S,
Sawazaki S, Numata M, Hayashi T, Yamada T, Sato T, Yukawa N, et al:
A case report of retroperitoneal liposarcoma resected six times for
16 years. Gan To Kagaku Ryoho. 45:1507–1509. 2018.(In Japanese).
PubMed/NCBI
|
|
41
|
Kuribayashi S, Nakai Y, Tsuji H, Yumiba S,
Hatano K, Nakayama M, Kakimoto K, Kubo C and Nishimura K: A case of
retroperitoneal liposarcoma in which magnetic resonance imaging was
useful in the decision of resection of primary and recurrent
tumors. Hinyokika Kiyo. 64:145–149. 2018.(In Japanese). PubMed/NCBI
|
|
42
|
Alsalameh BK and Abufkhaida BS: Recurrent
abdominal liposarcoma presenting with intestinal obstruction. J
Surg Case Rep. 2019:rjz1882019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li CF, Yang XR, Yao J, Huang JJ, Tan N,
Zhang SY, Xu GQ and Zheng H: Giant recurrent mixed-type liposarcoma
of the retroperitoneum: Report of a case and review of literature.
Int J Clin Exp Pathol. 12:1406–1411. 2019.PubMed/NCBI
|
|
44
|
Guo J, Qiu F, Zhao J, Lu Q, Fu W, Xu Q and
Huang D: Case report: Retroperitoneal sarcoma in six operations:
Our experience in operative management of blood vessels. Front
Oncol. 12:8850332022. View Article : Google Scholar : PubMed/NCBI
|
